AP

AMIR PANAH — 510(k) & De Novo Consultant (IVD/Wearable Digital)

Principal Consultant / Director of Regulatory Affairs / VP of Quality

A distinguished Chief Regulatory & Quality Strategist and VP, Global Regulatory Affairs, with over 20 years of dedicated expertise in navigating the complex global regulatory landscape for medical devices and IVDs. Amir possesses a remarkable track record of success in securing market access and ensuring compliance across stringent regulatory bodies including the FDA, EU MDR, UKCA, and Asia-Pacifi...

Experience: 17+ years

Submissions: 14 510(k), 8 PMA

Expertise & Specializations

Regulatory Pathways

510(k)De NovoPMAIDEPost-market

Device Specialties

IVDWearable DigitalOphthalmicGeneral Surgery

Regions Served

AMIR PANAH provides regulatory consulting services to clients in:

United States (FDA)European Union (MDR/IVDR)Canada (Health Canada)Asia-Pacific

Credentials & Recognition

Education & Credentials

Possesses a Bachelor of Engineering in Mechanical Engineering from Mohawk College, providing a strong technical foundation crucial for understanding complex medical devices. This engineering background is augmented by continuous professional development, ensuring a deep grasp of both the technical and regulatory aspects of medtech innovation. This combination of formal engineering education and specialized regulatory knowledge equips them to effectively bridge the gap between product development and market compliance.

Certifications

CARE Certification
TÜV SÜD
2024
EU MDR & IVDR Technical Documentation Auditing
TÜV SÜD
2024
ISO 13485:2016 Internal Auditor
BSI
MD-QMS
BSI
2018
Six Sigma Green Belt
ASQ
2008

Professional Experience

A seasoned regulatory affairs executive with over 20 years of experience leading global market access and compliance for Class II/III medical devices and IVDs. Proven success in building and scaling regulatory frameworks across FDA, EU MDR, UKCA, and APAC markets, including advising on high-stakes FDA interactions and M&A due diligence. Career highlights include directing global regulatory strategy for 30+ firms, achieving over 50 regulatory approvals across 10+ jurisdictions, and enabling over $500M in cumulative market access. Expertise spans various senior roles, including VP of Quality and Director of Regulatory Affairs, demonstrating a comprehensive understanding of the regulatory lifecycle. Their extensive consulting engagements with numerous medtech companies underscore their adaptability and proven ability to deliver results.

Former Notified Body Auditor
EU MDR expertise

Executive Summary

Professional Overview

A distinguished Chief Regulatory & Quality Strategist and VP, Global Regulatory Affairs, with over 20 years of dedicated expertise in navigating the complex global regulatory landscape for medical devices and IVDs. Amir possesses a remarkable track record of success in securing market access and ens...

Core Specializations

Regulatory Pathways

510(k)De NovoPMAIDEPost-market

Device Specialties

IVDWearable DigitalOphthalmicGeneral Surgery

Services Offered

ISO 13485 Consulting
Quality management system development, gap analysis, and ISO 13485 certification support for medical device manufacturers.
FDA Mock Audit
Pre-inspection preparation, mock FDA audits, and readiness assessments to ensure compliance before official FDA inspections.
ISO 14971 Consulting
Risk management system development, risk analysis, and ISO 14971 compliance support for medical device risk management.
Regulatory Pathway Assessment
Strategic assessment to determine the appropriate FDA regulatory pathway (510(k), De Novo, PMA) for your medical device.
510(k) Authoring & Submission
Complete 510(k) submission preparation, documentation authoring, and FDA submission management.
De Novo & PMA Strategy
Strategic planning and support for De Novo and PMA pathways, including clinical trial design and FDA meeting preparation.
QMS Setup & Implementation
Quality management system design, implementation, and validation to meet FDA and ISO requirements.
Post-Market Support
Post-market surveillance, adverse event reporting, and ongoing regulatory compliance support.

Cruxi Independent Snapshot

Best suited for

  • • MedTech companies seeking expert regulatory guidance

Experience signals

  • Regions: US, EU, CA, APAC
  • Background: 17+ years of regulatory experience.

Cruxi view

With over 20 years of dedicated experience, Amir Panah is a distinguished regulatory and quality strategist for medtech companies, boasting a profound understanding of complex global regulatory landscapes. His extensive track record includes securing market access and ensuring compliance across stringent bodies like the FDA, EU MDR, and UKCA, making him an invaluable asset for navigating high-stakes FDA interactions and M&A due diligence. Amir's expertise extends to cutting-edge areas such as Software as a Medical Device (SaMD) and AI/ML technologies, positioning him as a leader in emerging regulatory frontiers. His proven success in achieving over 50 regulatory approvals across more than 10 jurisdictions, coupled with a deep technical foundation from his engineering background, allows him to effectively bridge product development with market compliance, driving strategic growth for medtech organizations.

This analysis is generated by Cruxi AI using public information and may not capture the full scope of the consultant's experience.

Contact AMIR PANAH

Share a brief overview of your device and timeline. Cruxi will forward your request to AMIR PANAH and help structure next steps.

Contact Now